[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.202.12. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
June 21, 2000

Benefit of Prophylactic Mastectomy for Women With BRCA1 or BRCA2 Mutations—Reply

Author Affiliations
  • 1Memorial Sloan-Kettering Cancer Center, New York, NY
  • 2Harvard School of Public Health, Boston, Mass
  • 3Dana-Farber Cancer Institute, Boston
JAMA. 2000;283(23):3071-3072. doi:10.1001/jama.283.23.3068g

In Reply: Ms Miller and Dr Singer are correct that only those women destined to die of contralateral breast cancer would actually live longer as a result of having had prophylactic contralateral mastectomy. Many others would avoid the morbidity of treatment for a second breast cancer. When decisions about cancer prevention strategies need to be made, there is no way to predict whether an individual woman is destined to live out her life cancer-free, develop a cancer that can be cured, or one that ultimately proves fatal. As is the case for many preventive measures, to save a few lives, many individuals must be treated.

First Page Preview View Large
First page PDF preview
First page PDF preview
×